2025 University of Illinois Cancer CenterWinter CME Series
January 15, 2025 – Hematologic Malignancies – Update from ASH
January 22, 2025 – Women and GU Cancers
January 29, 2025 – Emerging Paradigms in the Management of Oncology Patients
THE LIVE STREAM LOGIN INSTRUCTIONS WILL BE SENT TUESDAY BEFORE EACH OF THE SESSIONS.
YOU MUST BE REGISTERED TO RECEIVE THE LOGIN INSTRUCTIONS.
Morgan's on Fulton
950 W Fulton Market
Chicago, Illinois 60607
312-526-3606
950 W Fulton Market
Chicago, Illinois 60607
312-526-3606
Organized By:
Hosted By:
Conference Information
THE DETAILS FOR EACH SESSION
ARE AVAILABLE BELOW BY SESSION DATE.
REGISTRATION FEES PER SESSION:
INDUSTRY = $200
MD/DO = $100
APP = $50
STUDENTS/FELLOWS = $0.00
UNIVERSITY OF ILLINOIS CHICAGO STAFF, FACULTY AND AFFILIATES = $0.00
Registration
- Educational Presentations on hematologic malignancies
- Late-breaking and novel treatment recommendations and findings incorporated into each session
- Faculty panel discussions with audience participation
- Interaction with Course Chairs & Faculty Presenters
- Complimentary networking event from 6-7pm for all Attendees, Faculty, and invited sponsors and exhibitors
- Catch up with Colleagues and Friends
- Exhibits with over 20 Industry Organizations Represented
- Non-CME Ancillary Event Sponsored by during the Mid-Session Break
- Registration Bag with Printed Program Materials, Bag Inserts and Exciting Swag
- Great local food
- Free Parking with a validated ticket from the Conference Onsite Staff
Educational Goal
learning Objectives
After participating in these activities, learners will be better able to:
- Discuss advancements and optimal strategies for bispecific T-cell engagers and novel therapies in Non-Hodgkin Lymphoma (NHL).
- Review novel advancements in CAR T-cell therapy for NHL and leukemias.
- Explain how to optimize treatment selection in Multiple Myeloma (MM), including the use of minimal residual disease (MRD) in the therapeutic setting.
- Review the latest treatment approaches in Acute Lymphoblastic Leukemia (ALL) and Acute Myeloid Leukemia (AML).
Target Audience
Preliminary Agenda
Day 1 – Wednesday, January 15, 2025
1:00 – 2:00pm – Registration, Exhibits, and Lunch
2:00 – 2:05pm – Introduction
2:05 – 2:50pm – Update on novel treatment strategies including bispecific T-Cell engagers in Non-Hodgkin Lymphoma (Paul Rubinstein, MD – University of Illinois Cancer Center)
2:50 – 3:35pm – Review the advances in cellular therapy for the treatment of Non- Hodgkin Lymphoma and Leukemias (Carlos Galvez, MD – University of Illinois Cancer Center)
3:35 – 4:35pm – Break, Exhibits, Non-CME Ancillary Event, Afternoon Pick Me Up
4:35 – 5:20pm – Updates on Myeloma treatment including the use of Minimal Residual Disease (Matias Sanchez, MD – University of Illinois Cancer Center)
5:20 – 6:05pm – OPEN FORUM: Latest treatments in ALL and AML (Noah Birch, MD – University of Illinois Cancer Center and Harry Sequeira, MD – Cook County Health)
6:05 – 7:00pm – Exhibits
Session 1 Materials
• PROGRAM HANDOUT
• SIGN IN SHEET
• PRODUCT THEATER SIGN IN SHEET
• PRE TEST
• POST TEST, EVAL, CLAIM CREDIT - This will be shared via email onsite.
Series Course Chair
Matias E. Sanchez, MD
Assistant Professor of Medicine
Division Hematology/Oncology
University of Illinois Cancer Center
Chicago, IL
Session Chair
Faculty Presenters
Paul Rubinstein, MD
Associate Professor of Medicine
Department of Medicine, Division of Hematology and Oncology
University of Illinois Cancer Center
Chicago, IL
Matias E. Sanchez, MD
Assistant Professor of Medicine
Division Hematology/Oncology
University of Illinois Cancer Center
Chicago, IL
Harry Sequeira, MD
Fellow
Hematology Oncology
Cook County Health
Chicago, IL
Educational Goal
learning Objectives
After participating in these activities, learners will be better able to:
- Discuss the current and future applications of newly approved targeted therapies across breast cancer sub-types
- Identify the side effects of innovative, practice-changing therapies and incorporate them into community practice
- Review new diagnostics and treatments in the management of Renal, Urothelial, and Prostate cancers
Target Audience
Agenda
Day 2 – Wednesday, January 22, 2025
1:00 – 2:00pm – Registration, Exhibits and Lunch
2:00 – 2:05pm – Introduction
2:05 – 2:40pm – Advancements in Genitourinary Oncology: Focus on Renal and Urothelial Cancers (Thomas Westbrook, MD – Rush University Medical
Center)
2:40 – 3:15pm – Personalized Medicine in Prostate Cancer (Mohammad Atiq, MD - University of Chicago)
3:15 – 3:35pm – Case Studies in Genitourinary Malignancies (Neha Hippalgaonkar, MD - University of Illinois Cancer Center)
3:35 – 4:35pm – Break, Exhibits, Non-CME Ancillary Event, Afternoon Pick Me Up
4:35 – 5:20pm – Current Trends and Future Directions in Gynecological Cancers (Shweta Gupta, MD and Vinod Solipuram, MD - Cook County Health)
5:20 – 6:05pm – Precision Medicine in Breast Cancer: Multidisciplinary Perspectives (Abiola Ibraheem, MD - University of Illinois Cancer Center)
6:05 – 7:00pm – Exhibits
Session 2 Materials
Series Chair
Matias E. Sanchez, MD
Assistant Professor Medicine
Division Hematology/Oncology
University of Illinois Cancer Center
Chicago, IL
Session Chair
Abiola Ibraheem, MD
Assistant Professor
Division of Hematology/Oncology
Department of Medicine
Center for Global Health
University of Illinois Cancer Center
Chicago, IL
Faculty Presenters
Mohammad Atiq, MD
Assistant Professor of Medicine
University of Chicago
Chicago, IL
Shweta Gupta, MD
Cook County Health
Chicago, IL
Neha Hippalgaonkar, MD
Fellow
Department of Medicine
Division of Hematology and Oncology
University of Illinois Cancer Center
Chicago, IL
Abiola Ibraheem, MD
Assistant Professor
Division of Hematology/Oncology
Department of Medicine
Center for Global Health
University of Illinois Cancer Center
Chicago, IL
Vinod Solipuram, MD
Fellow
Cook County Health
Chicago, IL
Thomas Westbrook, MD
Assistant Professor
Department of Internal Medicine
Rush University Medical Center
Chicago, IL
Educational Goal
learning Objectives
After participating in these activities, learners will be better able to:
- Explain the limitations of current registrational studies as they apply to minority populations and FDA guidance for proving this racial disparity (health equity)
- Describe the principles of antibody-drug conjugate therapy and current approved indications
- Discuss the principles of biological cell engagers/cell therapies and current approved indications
- Identify currently approved and emerging diagnostics for early cancer detection and minimal
residual disease
Target Audience
Agenda
Day 3 – Wednesday, January 29, 2025
1:00 – 2:00pm – Registration, Exhibits and Lunch
2:00 – 2:05pm – Introduction
2:05 – 3:00pm – Innovative T-Cell Engagers and Adoptive T-Cell Therapies in Lung Cancer, Melanoma, and Soft Tissue Sarcoma (VK Gadi, MD – University of Illinois
Cancer Center and Kai He, MD – Ohio State University Comprehensive Cancer Center)
3:00 – 3:40pm – Approved and Emerging Diagnostics for Early Cancer Detection and Minimal Residual Disease in Colon and Lung Cancer (Gayatry Mohapatra, MD – University of Illinois Cancer Center)
3:40 – 4:40pm – Breaks, Exhibits, Non-CME Ancillary Event, Afternoon Pick Me Up
4:40 – 5:25pm – Principles of Antibody-Drug Conjugate Therapy and Current Approved Indications in Lung and Ovarian Cancer (Rajat Thawani, MD – University of Chicago)
5:25 – 6:00pm – HEALTHY EQUITY - Discuss limitations of current registrational studies as they apply to minority populations and FDA guidance for proving this racial disparity (Ryan Nguyen, MD – University of Illinois Cancer Center)
6:00 – 7:00pm – Exhibits
Session 3 Materials
Series Course Chair
Matias E. Sanchez, MD
Assistant Professor Medicine
Division Hematology/Oncology
University of Illinois Cancer Center
Chicago, IL
Session Chair
Ameen Salahudeen, MD, PhD
Assistant Professor of Clinical Medicine
University of Illinois Chicago
Chicago, IL
Faculty
VK Gadi, MD, PhD
Deputy Director, University of Illinois Cancer Center
Professor and Director, Medical Oncology, UIC Department of Medicine
University of Illinois Cancer Center
Chicago, IL
Kai He, MD, PhD
Medical Oncologist
Assistant Professor
Thoracic Oncology
Ohio State University Comprehensive Cancer Center
Columbus, OH
Rajat Thawani, MBBS
Medical Oncologist
Assistant Professor of Medicine
Lung Cancer Specialist
University of Chicago
Chicago, IL
Gayatry Mohapatra, MD, PhD
Visiting Assistant Professor of Pathology
Department of Pathology
University of Illinois Chicago College of Medicine
Chicago, IL
Ryan Nguyen, DO
Assistant Professor of Clinical Medicine
Director, Precision Oncology Tumor Board
University of Illinois Cancer Center
Chicago, IL
Support Opportunities
Click HERE for the sponsorship opportunity details.
Click HERE for Exhibitor Information
To complete the application, please go to: https://cmersvp.com/exhibit-processing-form/
HOW TO GET TO Morgan's on Fulton
Morgan’s on Fulton
950 W Fulton Market
Chicago, IL 60607
312-526-3606
morgansonfulton.com
Parking and Public Transit Information
We will be contracting with nearby parking lots to offer convenient parking options. The conference organizers will validate parking tickets. More information will be provided closer to the session dates.
Public Transportation:
Morgan Station Green/Pink CTA Station
Chicago's Morgan Station is located at the crossroads of N Morgan Street and W Lake Street, right in the heart of Fulton Market and the West Loop. From there, riders can get anywhere on the Pink or Green "L" lines, which include stops that span from Harlem in Forest Park all the way to 63rd Street on the city's South Side and from 54th/Cermak in Cicero to downtown.
Ashland Green/Pink CTA Station:
A few blocks from Morgan Station is Ashland Station, a dual connecting entry point to the Pink and Green subway lines. It's farther west where W Lake Street and Ashland Avenue intersect.
CTA Bus Lines in Fulton Market:
Two CTA bus lines service the neighborhood: the 8, which runs north and south with stops at Halsted and Randolph, and the 20, which runs east and west with stops at Washington and Halsted.
Accreditation
This activity is jointly provided by Global Education Group and myMedEd.
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and myMedEd, Inc. Global is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation
Global Education Group designates these live activities for a maximum of 3.0 AMA PRA Category 1 Credits™ each. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Global Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or [email protected].
Instructions for Obtaining Credit
To receive credit, participants must attend the activity in its entirety. Participants must also score at least 70% on the post-test and submit it with the evaluation. Upon completion of the evaluation, participants can claim credit and produce a certificate, which will be printable and emailed to the address provided on the form.
Fee Information & Refund/Cancellation Policy
REGISTRATION FEES PER SESSION:
INDUSTRY = $200
MD/DO = $100
APP = $50
STUDENTS/FELLOWS = $0.00
UNIVERSITY OF ILLINOIS CHICAGO STAFF, FACULTY AND AFFILIATES = $0.00
Cancellations and refunds will be processed based on the following:
Up to 30 days prior to the conference = 100%
29 - 15 days prior to the conference = 50%
14-7 days prior to the conference = 25%
6-0 days prior to the conference = 0%
If you would like to request a refund, please email [email protected]
System Requirements
Below is a table detailing the minimum requirements for streaming a Zoom Webinar across different platforms:
Windows, macOS, iOS, and Android.
Notes:
• For best performance, use a wired internet connection for desktop/laptop or a strong Wi-Fi signal for mobile devices.
• Close unnecessary applications to optimize CPU and RAM usage during webinars.
• For webinars with high audience engagement (e.g., Q&A, polls), ensure you’re using the latest version of Zoom for enhanced features.
Disclosures of Relevant Financial Relationships
Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.
All relevant financial relationships have been mitigated.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and myMedEd do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Americans with Disabilities Act
Event staff will gladly assist you with any special needs (I.e., physical, dietary, etc.). Please contact myMedEd, inc. before the live event at (800) 973-0665 x2.
Educational Goal
Target Audience
learning Objectives
After participating in these activities, learners will be better able to:
- Participants will be able to evaluate the efficacy and safety of using PARP inhibitors in managing HRR-mutated metastatic prostate cancer, including potential side effects and monitoring parameters.
- Participants will be able to review the latest guidelines and recommendations for peri-operative therapy in localized rectal cancer.
- Participants will identify the role and significance of biomarkers in early and advanced-stage non-small
cell lung cancer
Agenda
Day 1 – Wednesday, January 24, 2024
1:00 – 2:00pm – Registration, Exhibits, Ancillary Events
2:00 – 2:05pm – Introduction
2:05 – 2:50pm – Shifting Paradigms in the Treatment of Metastatic Prostate Cancer
2:50 – 3:35pm – The Evolving Landscape of Peri-operative Therapy for Localized Rectal Cancer: What Clinicians Need to Know
3:35 – 4:35pm – Break, Exhibits, Ancillary Events
4:35 – 5:20pm – Navigating Neoadjuvant Options: Current Updates in the Perioperative Treatment for Early-Stage Lung Cancer
5:20 – 6:05pm – Precision Oncology: Leveraging Biomarkers for First-Line Treatment in NSCLC
6:05 – 7:00pm – Exhibits, Ancillary Events
Session 1 Materials
Series Course Chair
VK Gadi, MD, PhD
Deputy Director, University of Illinois Cancer Center
Professor and Director, Medical Oncology, UIC Department of Medicine
University of Illinois Cancer Center
Chicago, IL
Co-Chair
Faculty
Educational Goal
Target Audience
The target audience for this conference is medical oncologists, hematologists, pathologists, oncology
nurses, fellows, residents, advanced practice providers, family practitioners, primary care practitioners,
allied health professionals, and other providers interested in the care of patients with cancer.
learning Objectives
After participating in these activities, learners will be better able to:
- Discuss current and future roles of newly approved targeted therapies in all breast cancer subtypes
- Understand the side effects of practice-changing novel therapies and their integration into community practice
- Discuss emerging strategies for patients with platinum-resistant ovarian cancer
Agenda
Day 2 – Wednesday, January 31, 2024
1:00 - 2:00pm – Registration, Exhibits, Ancillary Events
2:00 – 2:05pm – Introduction
2:05 – 2:50pm – Recent Updates in Early-Stage Breast Cancer
2:50 – 3:35pm – Metastatic Breast Cancer Overview: Come Learn all the new Study Acronyms!
3:35 – 4:35pm – Break, Exhibits, Ancillary Events
4:35 – 5:20pm – Update in Genetics for the Oncologist
5:20 – 6:05pm – Incorporating Immunotherapy and other New Agents in Endometrial and Cervical Cancers
6:05 – 7:00pm – Exhibits, Ancillary Events
Series Course Chair
VK Gadi, MD, PhD
Deputy Director, University of Illinois Cancer Center
Professor and Director, Medical Oncology, UIC Department of Medicine
University of Illinois Cancer Center
Chicago, IL
Co-Chair
Faculty
Kent Hoskins, MD
Eileen Lindsey Heidrick Professor in Oncology and Professor of Medicine
Department of Medicine, Division of Hematology/Oncology
University of Illinois Cancer Center
Chicago, IL
Educational Goal
Target Audience
learning Objectives
After participating in these activities, learners will be better able to:
- Discuss the optimal strategies for the use of CAR T Cell and bispecific T-cell engagers in Diffuse Large B Cell Lymphoma
- Explain how to optimize treatment selection in Multiple Myeloma, including the use of bispecific T- Cell engagers
- Identify novel treatment approaches in Acute Lymphoblastic and Acute Myeloid Leukemia
Agenda
Day 3 – Wednesday, February 7, 2024
1:00 – 2:00pm – Registration, Exhibits, Ancillary Events
2:00 – 2:05pm - Introduction
2:05 – 2:50pm – How to best incorporate CAR T and new targeted immunotherapy in DLBCL
2:50 – 3:35pm – Management of newly diagnosed and relapsed Multiple Myeloma in 2024
3:35 – 4:35pm – Break, Exhibits, Ancillary Events
4:35 – 5:20pm – Emerging induction and consolidation regimens in Acute Lymphoblastic Leukemia
5:20 – 6:05pm – Latest advancements in targeted therapy in Acute Myeloid Leukemia
6:05 – 7:00pm – Exhibits, Ancillary Events
Series Course Chair
VK Gadi, MD, PhD
Deputy Director, University of Illinois Cancer Center
Professor and Director, Medical Oncology, UIC Department of Medicine
University of Illinois Cancer Center
Chicago, IL
Co-Chair
Faculty
Support Opportunities
Click HERE for the sponsorship opportunity details.
If you are interested in a Product Theater or Onsite Meeting Space, please email
[email protected] to discuss availability before you complete the application.
To complete the application, please go to: https://cmersvp.com/exhibit-processing-form/
For custom sponsorship packages, please get in touch with Nicole @ 815-861-9069 /
[email protected]
Click HERE to view the Agenda
Exhibitor Information - Logistics - Click HERE
UICMEW 4th Floor Diagram - Click HERE
HOW TO GET TO VENUE SIX10
Parking and Public Transit Information
Parking and Public Transit Map
PARKING WILL BE COMPLIMENTARY ONLY IN THE GARAGE LOCATION LISTED IN THE PARKING AND PUBLIC TRANSIT INFORMATION.
THE CONFERENCE ORGANIZERS WILL VALIDATE YOUR PARKING
Accreditation
This activity is jointly provided by Global Education Group and myMedEd.
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and myMedEd, Inc. Global is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation
Global Education Group designates these live activities for a maximum of 3.0 AMA PRA Category 1 Credits™ each. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Global Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or [email protected].
Instructions for Obtaining Credit
In order to receive credit, participants must attend the activity in its entirety. Participants must also score at least a
70% on the post-test and submit it, along with the credit application and evaluation form. Statements of credit will
be emailed within 4 to 6 weeks following the program.
System Requirement
PC
1.4 GHz Intel Pentium 4 or faster processor (or equivalent)
Windows 10, 8.1 (32-bit/64-bit), Windows 7 (32-bit/64-bit)
512 MB of RAM (1 GB recommended)
Microsoft Internet Explorer 11 or later, Windows Edge browser, Mozilla Firefox, and Google Chrome
For HTML Client – Google Chrome (v70.0 & above), Mozilla
Firefox (v65.0 & above), and Edge (v42.0 & above)
MAC
1.83 GHz Intel Core Duo or faster processor
512 MB of RAM (1 GB recommended)
MAC OS X 10.12, 10.13 and 10.14
Mozilla Firefox, Apple Safari, Google Chrome
For HTML Client – Google Chrome (v70.0 & above),
Apple Safari (v12.0 & above), and Mozilla Firefox
(v65.0 & above)
Fee Information & Refund/Cancellation Policy
REGISTRATION FEES PER SESSION:
INDUSTRY = $200
MD/DO = $100
APP = $50
STUDENTS/FELLOWS = $0.00
UNIVERSITY OF ILLINOIS CHICAGO STAFF, FACULTY AND AFFILIATES = $0.00
Cancellations and refunds will be processed based on the following:
Up to 30 days prior to the conference = 100%
29 - 15 days prior to the conference = 50%
14-7 days prior to the conference = 25%
6-0 days prior to the conference = 0%
If you would like to request a refund, please email [email protected]
Disclosures of Relevant Financial Relationships
Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.
All relevant financial relationships have been mitigated.
Disclosure information coming soon...
The planners and managers at Global Education Group and MyMedEd have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and myMedEd do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Americans with Disabilities Act
Event staff will gladly assist you with any special needs (I.e., physical, dietary, etc.). Please contact myMedEd, inc. before the live event at (800) 973-0665 x2.
Organized By:
Hosted By: